AstraZeneca (AZN) Tops Q3 Views; Raises Guidance

October 30, 2008 7:12 AM EDT Send to a Friend
AstraZeneca plc (NYSE: AZN) reports Q3 EPS of $1.32, above the consensus of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login